Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new NIH grant/contract identifier was added to the study's list of other identifiers, indicating NIH funding attribution for the RUBY trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:57:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The author list in the Publications citation for the Dostarlimab NEJM paper has been deleted, altering the attribution shown for that study reference.
    Difference
    0.1%
    Check dated 2026-08-18T19:36:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new NEJM publication citation for Dostarlimab in primary advanced or recurrent endometrial cancer was added, listing authors and article details. The page revision history was updated from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-11T18:24:24.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a recent internal update to the site's revision. No visible content or user-facing changes are indicated.
    Difference
    0.0%
    Check dated 2026-07-21T12:38:58.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new publication citation has been added under Publications: 'Molecular Testing in Primary Advanced or Recurrent Endometrial Cancer: A Cost-Effectiveness Analysis' (JCO Precis Oncol, 2026). This update documents related research connected to the RUBY study.
    Difference
    0.0%
    Check dated 2026-07-14T09:31:41.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Two new scholarly references were added to the record, increasing the study's cited literature on dostarlimab-based therapy in endometrial cancer. The record revision was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:45.000Z thumbnail image

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.